Novel systems with novel properties for use in the treatment of metabolic syndrome
A fiber-based gel system addresses metabolic syndrome by simultaneously improving multiple metabolic parameters, providing a holistic treatment that stabilizes blood sugar and cholesterol levels without side effects or environmental harm.
Patent Information
- Application Number
- JP2023513428
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-08-26
- Filing Date
- 2021-08-24
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2041-08-24
AI Technical Summary
Current treatments for metabolic syndrome, which often involve polydrug therapy, are ineffective in addressing the multifactorial nature of the condition, lead to iatrogenic disorders, and are difficult for patients to adhere to, particularly in young subjects where weight-related imbalances are prevalent.
A mixture of dietary fibers, vegetable fats, phenols, terpenes, and sugars, forming a gel system that interacts with the intestinal contents to reduce fat and carbohydrate absorption, balance metabolism, and rebalance metabolic parameters, providing a systemic approach to treat metabolic syndrome without side effects.
The mixture effectively reduces waist circumference, improves metabolic functions, and stabilizes blood sugar and cholesterol levels, offering a holistic treatment without environmental pollution, and is suitable for long-term use.
Smart Images

Figure 0007577834000027 
Figure 0007577834000028 
Figure 0007577834000029
Abstract
Description
[Technical field]
[0001] The present invention provides a novel system with new properties in the form of a mixture or composition and its use in treating or aiding in the treatment of metabolic syndrome or one or more associated symptoms. [Background technology]
[0002] The metabolic syndrome is a set of metabolic changes associated with visceral obesity, including insulin resistance, hypertension, dyslipidemia (hypertriglyceridemia, low HDL levels), and visceral obesity.
[0003] This pathological condition is precisely defined in the "IDF consensus global definition of the metabolic syndrome published in 2006 by the International Diabetes Federation (IDF)". The condition is diagnosed based on the presence of a high waist circumference accompanied by at least two of the alterations described in this publication and reported in the glossary below, and an increase in risk factors for cardiovascular, hepatic and pancreatic decompensation is determined. These metabolic imbalances are linked to the development of insulin resistance that causes real changes in many organs and tissues in the body, but are primarily responsible for atherosclerosis, hepatic steatosis and the reduction of beta cells in the pancreas. This helps to explain why the metabolic syndrome is strongly correlated with an increased risk of developing cardiovascular disease and type II diabetes, one of the main causes of death in the Western population. Recent data show that the syndrome affects 10-40% of the population, with variability that depends on ethnicity, age and lifestyle (diet, physical activity). In this context, it is useful to highlight that in recent years there has been a significant increase in this syndrome, an increase in caloric intake, an increase in the consumption of more energy-dense foods, containing high levels of saturated fats and sugars but lacking nutrients, a decrease in physical activity, all conditions that have led to an increase in the frequency of obesity, an increase determined in particular by high waist circumference (an indicator of metabolic imbalance) that is considered a real epidemic at present. According to data from the World Health Organization, in 2016, more than 1.9 billion adults (18 years and older) were overweight (BMI ≥ 25), and of these, 650 million were obese (BMI > 30). These data, expressed as percentages, represent the world population as follows: in 2016, about 13% of adults (11% of men and 15% of women) were obese and 39% (39% of men and 40% of women) were overweight. Furthermore, in 2016, it was estimated that about 41 million children under the age of 5 were overweight or obese, and 340 million children and adolescents (5-19 years) were overweight or obese. Childhood obesity is also often characterized by increased visceral adiposity, insulin resistance, and is associated with predictive markers of type 2 diabetes and metabolic syndrome.A 2006 Italian study involving children from Southern Italy reported that 40.8% of obese children and 41.2% of obese adolescents had HOMA values indicative of insulin resistance (>2.5 and >4.0, respectively), whereas only 3.0% of normal-weight children and / or adolescents had HOMA values indicative of insulin resistance (p<0.0001 and p<0.002, respectively).It is therefore clear that the greater the degree of obesity, the greater the risk that obese children will become obese adults, and therefore preventive and therapeutic interventions must be set before adolescence, also taking into account that it is more difficult to permanently lose weight in obese teenagers due to a series of biological and psychosocial constraints.
[0004] Therefore, metabolic syndrome is a multifactorial disease, and although treatments acting on lifestyle (diet and physical activity) are the most effective, they are difficult to treat because they are difficult to follow. In general, in addition to behavioral advice, we tend to treat individual metabolic imbalances, such as glycemia with metformin, dyslipidemia with statins and fibrates, and hypertension with antihypertensive drugs, but it is easy to conclude that this approach is unsuccessful, since it not only does not treat the problem of its complexity, but also leads to further iatrogenic disorders and diseases caused by polypharmacy. It is also well known that polypharmacy is paradoxically associated with treatment failure, which is often due to poor adherence to complex treatments, increased side effects, inappropriate prescriptions, poor doctor-patient communication, and poor patient education (Volpe, M., G. Pignatelli and F. Paneni. "Polytherapy in cardiovascular prevention: Open problems." Italian Journal of Cardiology 13 (2012): 503-510). As reported by the IDF, various treatments for the individual components of metabolic syndrome include, for example: Treating atherogenic dyslipidemia by administering, for example, fibrates (αPPAR agonists), statins or combinations thereof, which may be complicated by side effects, with the aim of lowering TG and lowering ApoB and non-HDL cholesterol levels, increasing HDL-c levels, and lowering LDL-c levels; Treating hypertension, for example with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers; Examples include the use of metformin, thiazolinediones, acarbose, and the like to treat insulin resistance and hyperglycemia.
[0005] A multi-drug approach is not recommended in young subjects in whom metabolic imbalances are substantially related to body weight. In this context, pharmacotherapy and rapid weight loss are considered extreme interventions that can be used in severely obese children, those with a BMI >2 units at the 95th percentile, over 12 years of age, refractory to one year of dietary and behavioral therapy, with significant abdominal adiposity, glucose intolerance or insulin resistance, hepatic steatosis and hyperandrogenism, respiratory disorders, etc.
[0006] Various drugs or compositions have been reported in the literature that show efficacy in treating or assisting in the treatment of one or more symptoms associated with metabolic syndrome. Among products based on substances of natural origin, polysaccharide complexes based on cellulose, hemicellulose, pectin and mucilage have been reported (Stagi et al 2017 "Retrospective Evaluation of Metformin and / or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome" and Stagi et al 2015 "Policaptil Gel Retard significantly reduces body mass index and hyperinsulinism and may decrease the risk of type 2 diabetes mellitus (T2DM) in obese children and adolescents with family history of obesity and T2DM" Ital J Pediatr. 2015 Feb 2015). 15, 41:10. doi:10.1186 / s13052-015-0109-7), which, in association with drugs and / or an appropriate lifestyle and diet, further reduces BMI and insulin resistance and thus favors a general metabolic recovery. Data reported in the literature indicate the possibility of approaches different from the polypharmacological approach in the treatment of the metabolic syndrome.
[0007] The very high number of cases of metabolic syndrome and the constantly decreasing average age of onset of this pathological condition underscore the urgency of identifying new compositions for treating or assisting in the treatment of metabolic syndrome, preferably based on natural, and therefore non-synthetic, active substances, which in fact bring one or more of the pathological changes associated with the metabolic syndrome into normal parameters. Summary of the Invention [Means for solving the problem]
[0008] The present invention provides a system with novel properties, represented by a mixture of substance classes for the treatment of metabolic syndrome or as an adjunct in the treatment of metabolic syndrome, which as a whole represents a system of active substances, which contrasts the aforementioned multifactorial pathological conditions with a systemic approach and acts effectively and synchronously against all etiological pathogenic factors such as: By combating excess and / or incorrect nutrition (too many calories and nutrients causing blood sugar and lipid peaks that are difficult for the liver to manage), it reduces hunger and slows down and reduces the absorption of fats and carbohydrates. Countering imbalanced microflora (which promotes systemic inflammation, fat accumulation, and fatty liver) promotes more normal intestinal content; It can regulate the body's metabolic balance, thereby reducing excessive abdominal circumference (which leads to hepatic steatosis and systemic inflammation due to dysglycemia and dyslipidemia).
[0009] The inventive systems presented herein in the form of mixtures or compositions act to rebalance the metabolic control of the whole organism through physiological action alone.
[0010] Thus, advantageously, unlike current multi-drug therapy approaches where each clinical condition contributing to the pathology is treated individually, the system of the present invention allows for a systemic (holistic) approach with simultaneous therapeutic effect on the various factors that contribute to metabolic syndrome. By therapeutic effect, it is meant that the system (mixture or composition) of the present invention, with appropriate administration and dosing regimen, can improve or help improve one or more, at least two, preferably at least three, of the altered parameters associated with metabolic syndrome.
[0011] Furthermore, the mixture or composition of the present invention does not cause side effects at the metabolic level, since it acts in harmony with the physiological functions of the organism by utilizing its advantageous mechanisms.
[0012] As mentioned above, traditional treatments instead act symptomatically by forcibly adjusting every single imbalanced parameter, thereby exacerbating the syndrome and generating new imbalances that lead to the development of new diseases.
[0013] Furthermore, the compositions of the present invention are 100% environmentally friendly and biodegradable, and their use does not cause environmental pollution, unlike drugs whose components can accumulate in the environment and water and adversely affect the food chain.
[0014] Thanks to the set of all the components described and claimed, the mixture or composition according to the invention constitutes an active physiological system (APS), i.e. a complex system that, when placed in contact with water, is structured by forces of different natures that help to form a homogeneous gel system at its own kinetics. The system according to the invention, as reported in the examples section and in the figures, starts off with a low viscosity, but structures within minutes and continues to do so for several hours. The result is a homogeneous system that behaves in such a way even when placed at acidic, near-neutral or basic pH typical of the different parts of the gastrointestinal tract (see examples). This system therefore has a particular ease of use since it maintains its homogeneity in the digestive tract, and has the ability to adapt to the entire tract and mix with the food mass, despite the pH variations characteristic of these compartments.
[0015] It promotes the interaction with the intestine (kilo, microbiota, intestinal epithelium) in all its components. In fact, APS interacts with the intestinal contents (kilo), causing changes in physical properties (increased viscosity) and diluting the concentration of fats and carbohydrates. In particular, APS: Due to their characteristic viscosity, these substances are absorbed more slowly (delaying effect) and at the same time the total amount absorbed is reduced. Thanks to its characteristic viscosity, it normalizes intestinal transit and further promotes the elimination of fats (cholesterol and triglycerides) and carbohydrates (including glucose), which subsequently contributes to a re-equilibration of the intestinal flora and a more rapid and stable improvement of metabolic function. Thanks to its characteristic three-dimensional structure, it reduces the reabsorption of bile acids, helps to re-equilibrate the levels of circulating cholesterol, and thanks to its viscosity, it interposes itself between the intestinal contents (rich in fats and any irritants) and the mucosa, helping to protect it.
[0016] All of the above promotes better utilization of nutrients by the liver, promoting reorganization of blood glucose, cholesterol, triglyceridemia and reduction of abdominal circumference.
[0017] The stability of the product system was confirmed by rheological studies and fractionation / separation tests using the physical methods reported in the Examples section, which highlight the ability of the gel to withstand induced deformation stresses while maintaining its structure and homogeneity, a feature that is particularly useful during gastrointestinal transit where the product is subjected to compression and stress from peristaltic stimuli.
[0018] Therefore, the object of the present invention is to: A mixture comprising: 56% to 84% by weight of dietary fiber, 31% to 47% by weight of the mixture being represented by soluble fiber and 25% to 37% by weight of the mixture being represented by insoluble fiber; 0.28% to 0.42% by weight of vegetable fats; 0.08% to 0.16% by weight of vegetable phenols; 0.52% to 0.78% by weight of vegetable terpenes; 1.62% to 2.70% by weight of vegetable sugars; 6.2% to 9.3% by weight of water; 3.6% to 5.7% by weight of inorganic compounds of plant origin; and 1.84% to 2.76% by weight of nitrogen-containing substances of plant origin.
[0019] According to the invention, all components of the abovementioned mixture (except water) are of vegetable origin. The nitrogen-containing substances are essentially represented by proteins and amino acids.
[0020] The mixture can therefore also be defined as a mixture comprising 56% to 84% by weight of vegetable dietary fibre, of which 31% to 47% by weight of the mixture is represented by soluble fibre and 25% to 37% by weight of the mixture is represented by insoluble fibre, 0.28% to 0.42% by weight of vegetable fats, 0.08% to 0.16% by weight of vegetable phenols, 0.52% to 0.78% by weight of vegetable terpenes, 1.62% to 2.70% by weight of vegetable sugars, 6.2% to 9.3% by weight of water, 3.6% to 5.7% by weight of inorganic compounds such as acids and / or salts and / or esters of macroelements of vegetable origin, and 1.84% to 2.76% by weight of nitrogen-containing substances of vegetable origin, mainly proteins and amino acids.
[0021] - A composition comprising a mixture according to any of the embodiments provided herein and at least one excipient and / or carrier and / or pharma- ceutically acceptable natural flavor or food grade, said mixture constituting the active ingredient of said composition.
[0022] A mixture or composition according to any one of the embodiments provided herein for use in treating or adjunctly treating metabolic syndrome.
[0023] term The term metabolic syndrome in the present invention is to be understood as defined in the IDF consensus global definition of the metabolic syndrome published in 2006 by the International Diabetes Federation.
[0024] The above publications provide a global definition of the metabolic syndrome used in clinical practice, based on a combination of the parameters reported below. [Table 1] [Table 2]
[0025] The term central (abdominal) obesity according to the present invention has the meaning commonly used in medical practice. This condition can be easily evaluated using waist circumference according to parameters known to those skilled in the art, for example according to the above table. This condition, independently associated with each of the other components of metabolic syndrome, including insulin resistance, is an essential risk factor for the diagnosis of the syndrome as defined by IDF 2006. Insulin resistance is difficult to measure in routine practice and has not been shown to be a mandatory requirement.
[0026] The term atherogenic dyslipidemia describes the combination of high triglycerides (TG) and low levels of HDL-c, along with elevated apolipoprotein B (ApoB), small dense LDL particles, and small HDL particles, all of which are independently atherogenic. This is commonly seen in people with type 2 diabetes and metabolic syndrome.
[0027] Low HDL-c and high TG levels are often associated with insulin resistance, with or without type 2 diabetes, and both are risk factors for coronary heart disease (CHD).
[0028] The term macroelements herein has the meaning commonly understood in the field of nutrition and thus refers to elements present in the human body in relatively large amounts, the daily requirement of which exceeds 100 mg. This category includes calcium, chlorine, phosphorus, magnesium, potassium, sodium and sulfur (also called trace elements).
[0029] The term vegetable dietary fibre according to the present invention is that commonly used in the state of the art.
[0030] In particular, the term dietary fiber includes the remaining backbone of plant cell walls that is resistant to human digestive enzymes, modified cellulose, plant gums, lignin, and all types of polysaccharides that are indigestible by humans.
[0031] Physiological definition: "Dietary fiber is a dietary component that is resistant to degradation by the enzymes of the enzyme kit."
[0032] Chemical definition: "Dietary fiber is the sum of polysaccharides and lignin of non-starch origin."
[0033] Dietary fiber is present in many plants, such as oats, barley, beans, potatoes, dried fruits, apricots, apples, and brown rice.
[0034] In the present invention, the term plant-based dietary fiber refers to the set of dietary fibers present in one or more plants, and not to refined individual fibers such as microcrystalline cellulose.
[0035] The term "system with novel properties" refers herein to a mixture or composition that exhibits a novel behavior, i.e., a system in which the agents that make up the mixture operating in a specific environment (in this case the digestive system) give rise to a more complex behavior as a system. The properties themselves are not easily predictable, but represent a level of subsequent evolution of the system. The complex novel behavior is not a property of the individual entities and cannot be easily recognized or inferred from the behavior of lower level entities. [Brief description of the drawings]
[0036] [Figure 1] 1 shows a macroscopic evaluation of gel formation kinetics at different pH in three buffer systems with USP: phosphate buffer pH 6.4 and pH 8 and chloride buffer pH 1.5. 2.5 g of composition example 1 and 2.35 g of comparative example were dispersed in 150 ml of liquid medium, and the dispersion was mixed slowly for 1 minute and then placed in a small bath heated to 37° C. The macroscopic evaluation of gel formation kinetics shows that the gel formed by composition example 1, unlike the comparative example, is stable in the presence of high ionic strength and strong acidic pH, and is much more homogeneous at near-neutral pH and basic pH, thus making the system more user-friendly. [Diagram 2] FIG. 1 shows flow curves of APS sample composition example 1 and a comparative example subjected to slip gradients of 0.1 to 100 seconds. [Diagram 3] FIG. 1 shows the measurement of the linear viscoelastic region (LVER), elastic modulus (G′) and viscous modulus (G″). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0037] The invention therefore relates to a system with new properties in the form of a mixture comprising 56% to 84% by weight of dietary fibre, 31% to 47% by weight of the mixture being represented by soluble fibre and 25% to 37% by weight of the mixture being represented by insoluble fibre, 0.28% to 0.42% by weight of vegetable fats, 0.08% to 0.16% by weight of vegetable phenols, 0.52% to 0.78% by weight of vegetable terpenes, 1.62% to 2.70% by weight of vegetable sugars, 6.2% to 9.3% by weight of water, 3.6% to 5.7% by weight of inorganic compounds of vegetable origin and 1.84% to 2.76% by weight of nitrogen-containing substances of vegetable origin.
[0038] This system, which can be formulated by adding one or more suitable excipients and / or carriers and / or natural food grade or pharma- ceutically acceptable flavorings, is indicated for treating or aiding in the treatment of metabolic syndrome.
[0039] Thanks to the combination of all its components (soluble fiber, insoluble fiber and terpenes), the formulation constitutes an active physiological system (APS) that acts by interacting with the intestine (kilo, microflora, intestinal epithelium) in all its components. The APS forms a complex with the intestinal contents (kilo), causing a change in physical properties (increase in viscosity) and diluting the concentration of fats and carbohydrates. In particular, the APS: -It makes these substances absorbed more slowly (delaying effect) while reducing the total amount absorbed. Re-equilibrates the intestinal flora, which helps improve metabolic function more rapidly and consistently, normalizing intestinal transit and further promoting the elimination of fats (cholesterol and triglycerides) and carbohydrates (including glucose). It reduces the reabsorption of bile acids, helps to rebalance the levels of circulating cholesterol, and thanks to its viscosity, it interposes itself between the intestinal contents (rich in fats and any irritants) and the mucous membrane, helping to protect it.
[0040] In the system of the present invention, soluble and insoluble vegetable fibers result in the formation of a natural gel that has physiological effects occurring along the entire length of the gastrointestinal tract, improving transit and increasing satiety by slowing gastric emptying.
[0041] The high water absorption capacity (wbc or water binding capacity) of soluble fiber results in the formation of gels which cause a decrease in the absorption of nutrients such as carbohydrates and lipids and cholesterol.
[0042] This mechanism allows the postprandial blood glucose and lipid peaks to be controlled, which leads to an improvement in sugar and fat metabolic parameters over time.
[0043] Insoluble fiber functions, inter alia, as an agent that can increase fecal bulk, increase its total weight and accelerate its excretion, thereby reducing the absorption of nutrients, especially lipids.
[0044] For both obesity / high waist circumference and reversal of dysglycemia and dyslipidemia constituting metabolic syndrome, the presence of an "active substance" for the absorption of lipids and carbohydrates, reducing their bioavailability and avoiding postprandial glycemic peaks is necessary. Both of these effects are the result of the specific mixture of soluble and insoluble fibers contained in the system (mixture or composition) of the present invention, resulting in a sequestration effect and greater peristalsis that promotes the excretion of lipids and carbohydrates and any other related substances through the feces.
[0045] Both conditions require a product with the following chemical and physical properties: Ability to become viscous in conjunction with the presence of fibers. The ability to bind and retain water, expressed as water binding capacity.
[0046] Water binding capacity (≧20% for the systems of the present invention) describes the ability of a fiber to swell on contact with water and to retain water within its matrix even when subjected to physical stresses such as centrifugation.
[0047] The mechanism of action of the system of the present invention is derived from these characteristics and can be summarized in four basic points. thickening of the unmixed layer, i.e. covering the intestinal mucosa and partially covering nutrients in the path that lipids and carbohydrates must travel from the intestinal lumen to the enterocytes, prolonging their absorption time and causing a reduced and / or slower absorption of these substances (retarding effect), formation of an inert mass inside the gastrointestinal tract; In contrast to the mixing of nutrients with digestive enzymes, the viscosity of the intestinal contents increases, resulting in a decrease in the efficiency of digestion and a decrease in the absorption rate of digested nutrients; The adsorption and trapping of bile acids reduces the emulsion of lipids in the intestinal lumen, reducing the digestive efficiency of gastric and pancreatic lipase. The trapping effect of water-soluble fiber on bile salts prevents intestinal absorption, causing the liver to use more cholesterol to newly produce bile acids, lowering the net values of total cholesterol and LDL in the blood. The aim is to protect the intestinal mucosa and microflora from contact with high concentrations of lipids and carbohydrates.
[0048] This regulated action is typical of fiber and also of a mechanical mechanism of action, since it does not act on specific enzymes or receptors present in the intestinal lumen, but on the rheological properties of the carbohydrate and nutrients themselves.
[0049] The more concentrated the nutrient is due to excessive intake, the stronger its interaction with fiber, and the less concentrated it is, the less fiber will interfere with the rheological properties of the nutrient, making absorption more rapid.
[0050] Among the known important performance parameters are WBC and total fiber. The increase in total volume of the intestinal contents is precisely dependent on the aqueous portion where hydrophilic nutrients and lipid micelles dissolve together with the digestive enzymes, thereby diluting the concentration of nutrients and reducing and slowing down their absorption.
[0051] In other words, the particular mixture of soluble and insoluble fiber and other components of the system of the present invention, when contacted with water, causes the formation of a viscous gel that has high levels of WBC.
[0052] The inventors have surprisingly found that by careful selection of the components, in which at least 30% of the insoluble dietary fibre is α-cellulose and at least 15% of the insoluble dietary fibre is lignin, or at least 35% of the insoluble dietary fibre is α-cellulose and at least 17% of the insoluble dietary fibre is lignin, or at least 40% of the insoluble dietary fibre is α-cellulose and at least 18% of the insoluble dietary fibre is lignin, it is possible to obtain a system which expresses a gel resistant to pH variations, whose interaction with the water present in the digestive tract is stable at values ranging from pH 1.5 to pH 8 (see Examples). Said stability ensures compliance of the system in all parts of the digestive system from the stomach to the intestines. Furthermore, the systems of the present invention behave like pseudoplastic fluids, such that their viscosity decreases with increasing deformation rate (see the Examples section and Figures), decreasing from about 123 Pa.s at 100 s at 37° C. to 0.3 Pa.s at 0.1 s. These viscosity values indicate a slow gel formation that is convenient for use in the gastrointestinal tract, allowing effective mixing with the contents of the gastrointestinal tract.
[0053] The vibration tests carried out and reported in the Examples section also surprisingly show that the product has a wide LVER (linear viscoelastic region), considering the high lignin content of the insoluble fibres (which by their nature should resist gel formation and be poorly hydrated), thus confirming the stability of the product.
[0054] Finally, fractionation experiments have shown that the systems of the present invention resist separation while maintaining gel structure despite the shear forces, pressures and temperatures used, demonstrating the ability of the gel resulting from the system's interaction with water to resist induced deformation stresses and maintain its structure and homogeneity, a feature that is particularly useful during gastrointestinal transit where the product is subjected to compression and stress from peristaltic stimuli.
[0055] Comparative tests with similar compositions in which the insoluble fiber does not have the proportion of α-cellulose and lignin of the mixtures or compositions according to the present specification or claims show that the relevant characteristics for a better effectiveness of the product in the gastrointestinal tract are surprisingly improved, thereby making it possible to obtain a more effective effect in the treatment or aid in the treatment of the metabolic syndrome.
[0056] Thus, in a preferred embodiment, the invention relates to a mixture comprising 56% to 84% by weight of vegetable dietary fibre, 0.28% to 0.42% by weight of vegetable fats, 0.08% to 0.16% by weight of vegetable phenols, 0.52% to 0.78% by weight of vegetable terpenes, 1.62% to 2.70% by weight of vegetable sugars, 6.2% to 9.3% by weight of water, 3.6% to 5.7% by weight of inorganic compounds such as acids and / or salts and / or esters of macroelements of vegetable origin and 1.84% to 2.76% by weight of nitrogen-containing substances of vegetable origin, mainly proteins and amino acids, whereby 31% to 47% by weight of the mixture is represented by soluble fibre and 25% to 37% by weight of the mixture is represented by insoluble fibre.
[0057] Thus, in a preferred embodiment, the invention relates to a mixture comprising 56% to 84% by weight of vegetable dietary fibre, 0.28% to 0.42% by weight of vegetable fats, 0.08% to 0.16% by weight of vegetable phenols, 0.52% to 0.78% by weight of vegetable terpenes, 1.62% to 2.70% by weight of vegetable sugars, 6.2% to 9.3% by weight of water, 3.6% to 5.7% by weight of inorganic compounds such as acids and / or salts and / or esters of macroelements of vegetable origin and 1.84% to 2.76% by weight of nitrogen-containing substances of vegetable origin, mainly proteins and amino acids, whereby 31% to 47% by weight of the mixture is represented by soluble fibre and 25% to 37% by weight of the mixture is represented by insoluble fibre.
[0058] In a preferred embodiment, the dietary fibre is 59.7% to 80.8% by weight vegetable fibre and 33.2% to 45% by weight of the mixture is represented by soluble fibre and 26.5% to 35.8% by weight of the mixture is represented by insoluble fibre, or the dietary fibre is 63% to 77% by weight vegetable fibre and 35% to 43% by weight of the mixture is represented by soluble fibre and 28% to 34% by weight of the mixture is represented by insoluble fibre.
[0059] Embodiments in which at least 30% of the insoluble dietary fiber is alpha-cellulose and at least 15% of the insoluble dietary fiber is lignin, or at least 35% of the insoluble dietary fiber is alpha-cellulose and at least 17% of the insoluble dietary fiber is lignin, or at least 40% of the insoluble dietary fiber is alpha-cellulose and at least 18% of the insoluble dietary fiber is lignin are particularly preferred due to the advantageous effects disclosed in the Examples section.
[0060] In a particularly preferred embodiment, about 42% of the dietary fiber is α-cellulose and about 19% of the insoluble dietary fiber is lignin.
[0061] According to the present invention, in any embodiment described or claimed for both the mixture and the composition, the dietary fiber is at least two of the following dietary fibers: hemp, cotton, bamboo, konjac, glucomannan, oat, spelt, rice, corn, wheat, barley, baobab, carrot, prickly pear, radish, citrus albedo, stevia, linden, linen, hollyhock, mallow, acacia, xanthan gum, larch, Cyamopsis tetragonoloba, bracken, carob, Jerusalem artichoke, pea, soybean, plantain, dandelion, chicory, amaranth, agave, karkade, aloe vera, and is present within the mixture in the form of a flour, powder and / or an aqueous or hydroalcoholic extract.
[0062] Additionally, the mixture or composition of the present invention may include fiber in the form of inulin, glucomannan, and vegetable gums such as gum arabic, xanthan gum, larch gum, comma karaya.
[0063] The fibers shown above are hemp (plant), cotton (plant, fluff, seed), bamboo (plant), oat (plant, seed, cuticle), spelt (plant, seed, cuticle), rice (plant, seed, cuticle), corn (plant, seed, cuticle), wheat (plant, seed, cuticle), barley (plant, seed, cuticle), baobab (fruit), carrot (root), konjac (tuber), prickly pear (light-colored fruit), radish (horseradish) (root), citrus albedo, stevia (leaf, plant), linden (flower and bracts), flax (seed), marshmallow (root), hollyhock (leaf), acacia (gum arabic) (fruit, seed, leaf), xanthan gum, larch (larch gum), cluster bean (Cyamopsis tetragonoloba (guar gum), (buds, leaves, fruit), Brassica napus (karaya gum), carob (pod, seed), Jerusalem artichoke (root), pea (plant, fruit), soybean (seed, cuticle), plantain (seed), dandelion (root), chicory (root), amaranth (leaf), agave (plant), karkade (leaf, flower, seed), and aloe vera (plant, leaf).
[0064] Preferably, in any embodiment described or claimed herein, the mixtures or compositions of the present invention do not contain cellulose in microcrystalline form, in other words, the cellulose component is substantially contained in the vegetable flour or powder and not as a purified material therefrom.
[0065] The same applies to the lignin component.
[0066] In accordance with the present invention, the soluble fiber can be derived from aqueous extracts of the fibers listed above, or from flours of the fruits, plants and plant parts listed above.
[0067] As mentioned above, the insoluble fiber can be derived from grinding or powdering the plants listed below.
[0068] Hemp (plant), Cotton (plant, fluff, seed), Bamboo (plant), Oat (plant, seed, cuticle), Prickly Pear (shovel, fruit), Spelt (plant, seed, cuticle), Rice (plant, seed, cuticle), Corn (plant, seed, cuticle), Wheat (plant, seed, cuticle), Barley (plant, seed, cuticle), Baobab (fruit), Citrus albedo, Stevia (leaf, plant), Carob (pod, seed), Pea (plant, fruit, cuticle), Soybean (seed, cuticle), Agave (plant).
[0069] In the present invention, the prickly pear cactus may be opuntia ficus indica in any embodiment.
[0070] Thus, in a preferred form, the mixture or composition of the invention comprises insoluble fiber in the form of ground or powdered plant matter of the above plants or parts thereof (indicated in brackets).
[0071] The designation "plant" in parentheses indicates that the grind or powder is preferably made from the whole plant and not from individual parts of the plant.
[0072] According to the invention, the phenols can be derived from the extracts of plants containing dietary fibre and from the plant powders used, such phenols are therefore preferably contained in said powders and / or grinds and / or plant extracts.
[0073] The terpenes can be derived from one or more of the plants listed above. In a preferred embodiment, the terpenes contained in the mixture or composition of the present invention are mainly provided by stevia, which can be present therein, for example, in the form of a powder.
[0074] The nitrogen-containing substances of the present invention are also contained in plant extracts containing dietary fiber, and in the powders or ground products of the plants used.
[0075] In certain embodiments, the total fiber of the blend or composition of the present invention is glucomannan fiber from konjac, marshmallow, flax, lime, oat, stevia, prickly pear, and also includes inulin and gum arabic.
[0076] Among these, the soluble fibres are glucomannan, marshmallow, flax, linden, inulin and gum arabic, while the insoluble fibres are oat, stevia and prickly pear.
[0077] Nitrogen compounds are provided by glucomannan, marshmallow, flax, lime, oat, stevia, prickly pear, inulin, gum arabic, phenolic compounds from marshmallow, flax, lime, stevia, prickly pear, and to a lesser extent all the powders used, sugars and derivatives from marshmallow, flax, lime, stevia, prickly pear, and to a lesser extent all the powders used, and terpenes substantially from stevia.
[0078] In a preferred embodiment, the mixture or composition of the invention comprises or consists of: [Table 3]
[0079] The term "comprising" is used throughout the specification and claims when referring to the total composition of a mixture, which may be present at up to 0.5%, 1% or 2% in total due to minimum percentages of other substances, and may be undetectable or undetectable.
[0080] In one embodiment, the mixture or composition of the invention comprises or consists of: [Table 4]
[0081] The mixture of the present invention is composed of: [Table 5]
[0082] The present invention also relates to a composition comprising a mixture according to any of the embodiments provided herein and at least one excipient and / or carrier and / or a pharma- ceutically acceptable natural flavor, said mixture constituting the active ingredient of said composition.
[0083] According to one embodiment, the composition corresponds, in terms of classes of substances and relative proportions, to any of the embodiments of the inventive mixtures disclosed herein.
[0084] Examples of compositions are provided below. [Table 6] [Table 7] [Table 8] [Table 9] [Table 10] [Table 11]
[0085] The composition according to the invention may be provided as a powder in the form of a sachet, tablet or capsule.
[0086] The systems (mixtures or compositions) of the present invention, in any of the embodiments provided herein and in the claims, are indicated for or to aid in the restoration of one or more key indicator parameters of metabolic imbalance when they are altered.
[0087] These parameters are as follows (for which data must be provided within 12 months): · LDL cholesterol above 100 mg / dl and / or HDL cholesterol below 40 mg / dl in men and 50 mg / dl in women. · Triglyceride levels above 150mg / dl. · Fasting plasma glucose (IFG) of more than 100 mg / dl and / or impaired glucose tolerance (or impaired glucose tolerance) (IGT) of 140-199 mg / dl. High waist circumference in normal weight subjects (>94 cm in men and >80 cm in women).
[0088] The compositions of the invention may, for example, be administered at a minimum of 3g and a maximum of 5g, for example 3, 3.5, 4, 4.4, 5g, preferably divided into two doses, for example 1.5, 2, 2.25, 2.5g each, before the main meal.
[0089] Each dose taken before a meal may be formulated as a single dose, such as a granule sachet, tablet or capsule.
[0090] The present invention also relates to a mixture or composition according to any of the embodiments provided herein for use in the treatment of metabolic syndrome, or as an adjunct in the treatment of metabolic syndrome.
[0091] Treatment may involve taking a mixture or composition of the invention before a main meal, for example 30 minutes, 20 minutes, 15 minutes, 10 minutes.
[0092] If the composition is in the form of granules, when suspended in water or liquid, it must be ingested before it forms a gel after contact with the liquid.
[0093] Dosage example: For adults and children 8 years and older, 4 to 5 grams per day before two main meals.
[0094] The first improvements are already seen one month after the start of treatment, but it is advisable to take the product for at least 2-3 months. However, it is possible to repeat the treatment cycle several times throughout the year.
[0095] Thus, the mixture or composition is preferably administered before a main meal. If granules are used, they can be administered suspended in water or other liquid and shaken and taken immediately after mixing before a gel is formed in an appropriate amount and for an appropriate time, ranging from a few weeks to chronic intake, depending on the specific symptoms.
[0096] At any point in the specification and claims, the word comprising may be replaced with the word "consisting of."
[0097] The examples reported below illustrate the chemical and physical properties of the mixtures of the invention which demonstrate their novel properties.
[0098] The experimental data reported below are results obtained using the composition shown in Composition Example 1, although other composition examples provided herein gave similar results (data not shown).
[0099] The comparative data provided is obtained using compositions in which the oat fiber is replaced with microcrystalline cellulose.
[0100] example 1. Product Preparation The components of the products according to the provided composition examples are powders with a defined particle size distribution prepared starting from different parts of the plant such as flowers, fruits, roots, seeds, leaves, etc., using techniques known to the skilled artisan such as peeling, cutting, washing, blowing, sieving, drying, grinding and standardization (e.g. for the preparation of oat fiber and glucomannan flour), or extracts obtained by keeping selected and cut parts of the plant in a solvent such as water or a mixture of water and alcohol for various times, drug / solvent ratios and temperatures. Once concentrated and pasteurized, the extracts can undergo intermediate steps of centrifugation, filtration and adsorption on various types of substrates in order to standardize their content before being dried or dried.
[0101] The product contains three aqueous extracts, specifically hollyhock, linden and linseed.
[0102] The following diagrams show, by way of example, the production process of marshmallow root extract, lime extract and linseed extract.
[0103] A comparative composition is represented by composition 1 in which the oat fiber is replaced by crystalline microcellulose. [ka] [ka] [ka] [ka]
[0104] In order to increase the density and workability of the system, the components of the products according to the composition examples provided in the detailed description in the form of powder or dry extract were weighed, physically mixed and subjected to wet granulation.
[0105] The following example shows data obtained for Composition Example 1 provided in the detailed description.
[0106] All the components of APS interact through different kinds of forces when placed in water and contribute to the formation of a homogeneous product system with its own dynamics. This system is initially a gel with reduced viscosity, but structures within minutes to hours. The result is a homogeneous system that behaves as it does when placed in acidic, near-neutral or basic pH typical of different parts of the gastrointestinal tract.
[0107] This system therefore has particular usability since it maintains its uniformity within the digestive tract, adapting to the entire tract and having the ability to mix with the food mass.
[0108] Suspension and rheological characterization experiments of the products at different pH-times were carried out to study the physiological behavior.
[0109] 2. Experiments at various pH levels To evaluate gel formation at various pH levels, three buffer systems according to USP were prepared: chloride buffer pH 1.5, phosphate buffer pH 6.4, and pH 8. 2.5 g of Example 1 and 2.35 g of Comparative Example 2 were dispersed in 150 ml of liquid medium, and the dispersion was mixed slowly for 1 minute and then placed in a small bath heated to 37° C. Macroscopic evaluation of gel formation kinetics showed how the gel formed by Example 1, unlike the Comparative Example, is stable at near-neutral pH as well as basic pH, in the presence of high ionic strength and strong acidic pH, and is much more homogeneous, thus favoring the ease of use of the system.
[0110] 3. Rheological properties Rheology is the study of the flow and deformation of materials. In a rheometer, a sample undergoes shear deformation, i.e. it is squeezed between two surfaces. The lower surface is in contact with a part of the instrument that remains stationary, and the upper surface is in contact with a surface that moves with a certain force that causes a deformation (x) that can be a function of time, depending on the type of material (solid or liquid), or if the material is a liquid, all rotate with a certain speed (v). This deformation X or speed V is applied to the first layer of material, which is in direct contact with the moving surface of the rheometer. The layer of material immediately below is dragged from the top, but is less deformed, and has less v. This also applies to the layer immediately below, and so on, up to the bottommost layer, which is instead stationary, and does not undergo deformation or move with any speed. Thus, a gradient exists whether the top layer is simply moved, or moved continuously. However, in a rheometer, the inference is not about force, velocity, or displacement. All these parameters are rescaled as a function of the sample size.
[0111] For example, F is divided by the surface to which it is applied to obtain the stress. Viscosity is a measure of the resistance a liquid has against flow and is given by the ratio of the shear stress to the flow gradient (in Pa.s). The slip gradient is given by the ratio of the rotational speed to the gap thickness.
number
[0112] Viscosity and shear rate parameters In particular, two tests were performed on Composition Example 1 and the comparative composition to characterize the gel formed after the APS was introduced into water. 1- Determination of flow curve. Analysis parameters: shear rate 0.1-100s-1 Temperature 37℃ 3 Repetitions 2-Determination of the Linear Viscoelastic Region (LVER) Analysis parameters: shear strain 0.1-100% Frequency 5.0Hz Temperature 37℃ 3 Repetitions Equipment: Rotational Rheometer TA Equipment Structure: Plate cone C60mm GAP: 29μm Temperature: 37℃ 3 Repetitions
[0113] 3.1 Sample preparation: 1 L of thermostated drinking water at a temperature of 50° C. was added to a 2 L beaker.
[0114] For each test, 150 ml of water at 50°C was taken and placed in a 200 ml beaker.
[0115] For each measurement, one bag of granules was slowly added to the beaker and the suspension was manually stirred for 1 minute.
[0116] The time elapsed between gel preparation and measurement was 30 seconds.
[0117] 1 ml of the product was placed in a measuring vessel.
[0118] 3.2 Results: A flow curve determination test is used to measure the viscosity of the samples at various applied shear rates. The result is a graph showing the viscosity trend (n, Pa.s) as a function of shear rate (γ·, s-1). As can be seen from the graph shown in Figure 2, the behavior of the gel formed by the APS of Composition Example 1 was found to be comparable to a pseudoplastic non-Newtonian fluid, i.e., a fluid characterized by a decreasing viscosity as the flow gradient increases. Composition Example 1 has a lower viscosity of about 123 Pa.s at a flow gradient of 0.1 s-1 compared to the comparative example, which is characterized by a viscosity of about 206 Pa.s, indicating that the formation of the gel occurs more slowly and uniformly. This improves usability in the GI tract, allowing for more uniform mixing with the contents present in the GI tract, allowing for reduced side effects, thus promoting compliance with the product.
[0119] The linear viscoelastic region (LVER - Linear Visco Elastic Region) is determined by the shear strain value at which the sample deforms (deformation γ* ,%). By applying a shear force at a constant oscillatory frequency with increasing strength to the sample, the mechanical structure of the material is destroyed at a given deformation. At this point, the sample begins to behave like a liquid if it is able to flow. The parameters evaluated by this test are G' and G''. G' is the elastic (or conservative) modulus, which defines the ability of the material to store energy in the form of elastic deformation (reversible), and G'' is the viscous (dissipative) modulus, which defines the ability of the material to dissipate energy by slippage. Within the LVER, the modules G' and '' have constant values, since the response of the material is independent of the applied stress, since in this region the system does not undergo any changes. As shown in Figure 3, composition example 1 is characterized by a wider LVER than the comparative example, indicating the high stability of the gel formed by composition 1 against deformation stresses, despite the significant presence of lignin, a long-chain insoluble fiber.
[0120] Oat fibre has a higher amount of lignin, which by its nature should counteract (intercalate with) the formation of the glucomannan gel, resulting in poor hydration. Lignin is in fact a secondary plant metabolite with waterproofing properties with little hydration capacity. However, from the observation of the samples in water, the formation of a gel is evident, and in fact the components interact to form a homogeneous system, thus exhibiting new properties.
[0121] 4. Breaking test of the gel obtained from contact of the composition of the present invention with water Product used in the test (500 g) Composition Example 1 [ka]
[0122] Suspension of the composition in water The first step of the process involves hydrating the composition in water. The product of Composition Example 1 was hydrated in water at a ratio of about 1 / 50. Once in water, the product forms a gel.
[0123] To induce separation of the gel, more water was added up to a ratio of 1 / 60.
[0124] From the indications obtained from the rheological study, it was expected that the gel phase would dissolve spontaneously in a time interval exceeding 2 days. Centrifugation was thought to speed up the process. The product in suspension was therefore centrifuged immediately after dissolution, but again after 24 hours, since the phase remained stable. After waiting 24 hours and a second spin in the centrifuge, the gel was less viscous and therefore fractionation was carried out to limit undesired degradation phenomena. No other mechanical or thermal stresses were applied in order not to predetermine the breakage of the high molecular weight fibres.
[0125] The process was carried out with a first centrifugation step for the separation of the soluble and insoluble fractions. The separation of the soluble from the insoluble fraction was obtained after 20 minutes at 40000 rpm. The yield values for this fraction → insoluble fraction are shown in the general table below.
[0126] 4.1 Fractionation of components by molecular size and affinity to adsorption resin The supernatant of the centrifuge (soluble fraction) was then filtered by ultrafiltration using a spiral membrane wrapped with a MWCO of 10,000 Da.) This technique allows the separation of components at limited pressure through a semipermeable membrane according to their size (molecular weight).
[0127] The product with an initial dilution of 1 / 60 was still too viscous to be processed by ultrafiltration, the product was too viscous to run erratically, the membrane pressure was too high and the permeate flow was low, therefore the product was diluted a second time 1:2 with demineralized water (final dilution 1 / 120).
[0128] This dilution made it possible to process the entire product, although the process was slow and difficult.
[0129] At the end of the test, the membrane used had a negative performance test, indicating a blockage or damage during the process.
[0130] The high molecular weight retentate fraction was quantitatively lower and in any case lower than expected. In general, the process was particularly complex and high losses occurred. The low molecular weight fraction (permeate) was collected and subsequently treated on an adsorption resin column in order to further characterize this fraction as a function of its affinity behavior for the adsorption resin.
[0131] Fractionation using adsorptive resins was also fraught with difficulties due to the residual viscosity of the fraction and its film-forming activity, which determined its slow flow through the column, its adhesion to the inner surface of the column and possibly to the porous surfaces of the resin particles. As a result, the process was characterized by high process losses. Characterization of the soluble fraction is not satisfactory.
[0132] Below is a table containing the yields of the APS system according to Composition Example 1, the theoretically predicted results, and the results obtained from fractionation. [Table 12]
[0133] The fraction adsorbed to the resin was quantitatively higher than expected, as was the high molecular weight fraction.
[0134] Thus, the gel is highly stable and resistant to separation in its major component classes by application of physical methods.
[0135] The product, when subjected to physical fractionation techniques used to separate the various components, resists maintaining the gel structure despite the shear forces, pressures and temperatures used, providing fractionation results that were unexpected based on the composition; this experimental observation makes it possible to again support the novel behavior of the gel.
[0136] 5. Chemical Composition of Oat Fiber and Microcrystalline Cellulose The chemical composition of the following samples was measured: - 1 sample of oat fibre -Oat fiber 2 sample -Microcrystalline cellulose SF (Chicelmi, 18H0105).
[0137] In particular, analyses were performed to determine the following quantities: -Lignin. -α-cellulose (according to a procedure that includes the determination of the intermediate holocellulose, i.e., the fraction of cellulose enriched in hemicellulose). -Hemicellulose (obtained by difference). -ash.
[0138] Before carrying out the analysis, the material was sieved to reach a particle size of 40–60 mesh (0.25–0.42 mm), as is customary for lignocellulosic materials. Analyses were carried out in duplicate.
[0139] Furthermore, a portion of the flour was dried to constant weight in an oven at 103°C prior to analysis, thus results were conventionally referred to dry weight. A portion of this same portion was also used for the determination of ash content.
[0140] The following other measurements were also made in succession on the powder: - the content of soluble extractables in organic solvents, - the content of aqueous extract, - acid lignin (or klason), - Holocellulose content, - the content of α-cellulose, -Ash content.
[0141] Content of soluble extractables in organic solvent The determination of the organic extractive content was carried out using a Soxhlet extractor according to the method described in the TAPPI T204 standard, using a mixture of ethanol and toluene in a ratio of 1:2 as the solvent.
[0142] Aqueous extract content The determination of the aqueous extractables content was carried out according to the method described in the TAPPI T207 standard, using the same powder already free of organic extractables, and in this case using a Soxhlet extractor.
[0143] Considering that the measurement of both types of extract (aqueous and organic) requires that the residue extracted from the solvent in the flask is weighed and that the protein is not (or is barely) soluble in either the organic solvent used or in water, the value obtained in both measurements can be considered as the net amount of protein content of the analyzed material.
[0144] Lignin Content The determination of lignin was carried out using the method described in the TAPPI T222 standard, commonly called acid lignin or klason, using flour that had not already had both organic and aqueous extracts.
[0145] Considering that highly concentrated sulfuric acid is used for the determination of lignin, that proteins are considered to be completely soluble in such an acidic solution, and that the insoluble residue is weighed at the end of the procedure, the value obtained in this measurement can be considered as the net protein content of the analyzed material.
[0146] Ash content The ash content was measured in a muffle furnace at 525° C. for 1 hour according to the method described in the TAPPI T211 standard.
[0147] Considering that all organic material is assumed to have been decomposed up to the operating temperature, the value obtained in this measurement can be considered as the net protein content of the analyzed material.
[0148] Holocellulose Content Holocellulose is defined as all that remains of the extractive-free woody material once it has been delignified. In fact, its size can be determined by difference, since it corresponds to the sum of the residual cellulose and hemicellulose.
[0149] In particular, holocellulose (H) was obtained by arithmetic difference with the sum of other chemical components according to the following formula: H=100-(L+EO+EA+C) (all values expressed as %).
[0150] In this formula, the general parameters P (and in particular L, EO, EA, and C) are given by:
number
[0151] α-Cellulose content The α-cellulose content was measured directly as the residue from the treatment of holocellulose with 17.5% soda solution according to the procedure reported by Browning (Browning, BL, 1967, Methods of wood chemistry, Vol. I, Interscience Publishers. A Division of John Wiley and Sons Inc., New York) (Method IVALSA AC-21) with slight modifications. For the evaluation of α-cellulose, holocellulose was obtained to act as a precursor using the method of Norman and Jenkins, and the extracted powder was subjected to a series of alternating treatments with acidified sodium hypochlorite and sodium sulfite, repeated until the red color due to the occurrence of the Maule reaction disappeared.
[0152] It is generally believed that α-cellulose, as the fraction of holocellulose insoluble in strong alkaline solutions, is substantially proportional to the crystalline portion of cellulose in the lignocellulosic material.
[0153] Considering that 20% sulfuric acid is used in the procedure for the isolation of holocellulose, that proteins are expected to dissolve under these conditions, and that the insoluble residue is weighed at the end of the procedure, the value obtained to this extent can be considered as the net amount of protein content of the analyzed material.
[0154] Hemicellulose Content As already mentioned, hemicellulose is obtained by the difference between holocellulose and α-cellulose, as is often suggested in the technical scientific field. In particular, the value is obtained by calculating the difference. Hemicellulose = H-α-cellulose
[0155] result [Table 13]
[0156] Composition Example 1 statistical methods Quantitative data are presented as mean, standard deviation (sd), median, first and third quartiles (Q1-Q3), minimum and maximum, categorical data as absolute frequencies and percentages.
[0157] BMI was calculated and classified into four classes.
[0158] Analyses were performed using SAS 9.4 software.
[0159] Check the questionnaire If the patient declared that there were no changes in question 9, question 10 was expected to be left unanswered. In some cases, this did not happen. If the patient answered "not included in the changed parameters" to question 9 and entered an answer to question 10 (occurred 20 times in a total of 9 patients), question 10 was modified and considered to be blank (i.e., symptoms were not present). In question 10, 6 out of 15 patients were asked to answer simultaneously regarding the time of onset of effect of composition example 1 for controlling elevated blood glucose levels or impaired glucose tolerance. If the patient answered "not included in the changed parameters" in question 9, the corresponding variable in question 10 was left blank, otherwise the score of compound 1 was taken into account for both variables.
[0160] For question 9 about blood pressure, patient 1-05 indicated both sufficient and “not included in vital signs.” “Not included in vital signs” was considered.
[0161] Patient 1-03 indicated that he had not lost weight in question 11, but had lost weight in question 12. The answer to question 11 was considered to be "yes."
[0162] For patients 1-01 to 1-05 in question 3, the weight was entered before taking composition example 1, while for the other patients, the current weight on the day the questionnaire was filled in. Weight was taken into account for all patients when filling out the questionnaire, and for patients 1-01 to 1-05, it was calculated as "initial weight" - "weight loss" using the answer to question 12.
[0163] In three patients, question 6 was marked "no" but indicated that something was being followed in addition to taking Formulation 1. For these patients, a "yes" was considered the answer.
[0164] result Data were collected from 15 patients, 73% (11 of 15) were female, 53% (8 of 15) were aged 31-50 years, and 100% (15 of 15) were overweight or obese (Table 1). The patients' mean current weight was 97.27 (sd 14.04) and the mean BMI was 37.41 (sd 6.21).
[0165] In Tables 1–6, data are presented for the entire population. [Table 14]
[0166] 87% of the patients (13 out of 15) take Composition Example 1 for more than 3 months. 13 out of 15 patients (87%) take it in addition to something else, 67% (10 out of 15) also follow a diet program, 7 out of 15 (47%) also follow a regular physical activity program, and 7 out of 15 (47%) also take other drugs to control metabolic parameters. Five out of 15 patients (33%) suffer from diabetes and all of these (100%, 5 out of 5) are being treated for this disease. [Table 15]
[0167] 87% (13 of 15) of the patients declared that Formulation 1 was "good enough" to control LDL cholesterol. Also, 87% (13 of 15) declared that Formulation 1 was "good enough" to control triglycerides. 40% (6 of 15) of the patients declared that Formulation 1 was "not very" effective to control HDL cholesterol. 93% (14 of 15) of the patients did not include glucose tolerance in the parameters that were decreased. Also, 93% (14 of 15) of the patients did not include blood pressure in the parameters that were changed. [Table 16]
[0168] Eight of 15 patients (53%) received support from formulation 1 in controlling waist circumference changes after 3 months, whereas 2 of 15 patients (13%) did not see any improvement. For LDL cholesterol, 47% (7 of 15) patients were able to benefit after 3 months, whereas for HDL cholesterol, 40% (6 of 15) patients received support after 3 months. After 3 months, 43% (6 of 14) patients saw an improvement in controlling triglyceride changes. For fasting blood glucose changes, 57% (4 of 7) patients received benefit from formulation 1 after 2 months. [Table 17]
[0169] 93% of patients (13 of 14) lost weight. Patients lost a mean of 3.38 kg (SD 1.2), and the mean percentage change (weight loss / initial weight) was * 100) was 3.47% (SD 1.3).
[0170] Twelve of 14 patients (86%) forgot to take Formulation 1 for less than 10% of the time, and 15% (2 of 13) discontinued taking it for more than 2 days. [Table 18]
[0171] 50% of patients (7 / 14) declared that with Composition Example 1 their quality of life was improved "much". In 6 of 9 patients (67%) mood was improved, and none of the patients reported improvements in social life, performance at work or attention in daily activities. 89% (8 / 9) of patients declared that Composition Example 1, when combined with a diet program and a regular physical activity program, allows to avoid the use of drugs to control metabolic parameters. Safety of Composition Example 1 was considered "excellent" by 56% (5 / 9) and "good" by 44% (4 / 9). [Table 19]
[0172] The same tests were performed on Composition Examples 2, 3, 4 and 5 with results comparable to those reported in Tables 1-6 for Composition Example 1.
Claims
1. 1. A mixture comprising 56% to 84% by weight of vegetable fiber, 0.28% to 0.42% by weight of vegetable fat, 0.08% to 0.16% by weight of vegetable phenols, 0.52% to 0.78% by weight of vegetable terpenes, 1.62% to 2.70% by weight of vegetable sugars, 6.2% to 9.3% by weight of water, 3.6% to 5.7% by weight of inorganic compounds of vegetable origin, and 1.84% to 2.76% by weight of nitrogen-containing substances of vegetable origin, A mixture comprising 31% to 47% by weight of soluble vegetable fiber and 25% to 37% by weight of insoluble vegetable fiber.
2. 2. The mixture of claim 1, comprising 59.7% to 80.8% by weight of said vegetable fiber, 33.2% to 45% by weight of said soluble vegetable fiber, and 26.5% to 35.8% by weight of said insoluble vegetable fiber.
3. 3. The mixture of claim 1 or 2, wherein at least 30% of the insoluble plant fiber is alpha-cellulose and at least 15% is lignin.
4. 4. The mixture according to any one of claims 1 to 3, wherein the vegetable fibres are at least two of the following dietary fibres: hemp, cotton, bamboo, konjac, glucomannan, oat, spelt, rice, corn, wheat, barley, baobab, carrot, prickly pear, radish, citrus albedo, stevia, linden, linen, hollyhock, mallow, acacia, xanthan gum, larch, Cyamopsis tetragonoloba, bracken, carob, Jerusalem artichoke, pea, soybean, plantain, dandelion, chicory, amaranth, agave, karkade, aloe vera, and are present in the form of flour, powder and / or aqueous or hydroalcoholic extract.
5. 5. The blend of claim 4, wherein the vegetable fibers include glucomannan, oat, prickly pear, stevia, inulin and gum arabic fibers.
6. A composition comprising a mixture according to any one of claims 1 to 5, and optionally at least one pharma- ceutically acceptable or food grade excipient and / or carrier and / or natural flavor, said mixture constituting the active ingredient of said composition.
7. The composition of claim 6 in the form of granules, tablets, or capsules.
8. 8. A composition according to claim 6 or 7 for use in the treatment of metabolic syndrome or as an adjuvant in the treatment of metabolic syndrome.
9. The composition of claim 8 administered before a main meal.
10. The composition of claim 9 administered in a dosage of 1.5 to 2.5 g before each main meal.
Citation Information
Patent Citations
Dietary fiber composition capable of regulating blood glucose and blood lipid and preparation method of dietary fiber composition
CN106858621A
Compound dietary fiber meal-replacement solid beverage and preparation method thereof
CN110179037A
Pharmaceutical and dietetic compositions based on vegetable fibres
EP1679009A1
Oral and tubal nutrient composition
JP1994135838A
Diet food
JP2006042816A
